Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-17

Clinical Trial Update: A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating carboplatin and paclitaxel chemotherapy with nivolumab, with or without ipilimumab, in ovarian cancer including high-grade serous ovari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • PACLITAXEL (PACLITAXEL)
  • ipilimumab (ipilimumab)
  • nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: High Grade Serous Ovarian, Fallopian Tube | Phase 1 | Status: COMPLETED